ML24128A216

Shine Technologies, LLC, Submittal of Annual Financial Report

ML24128A216
Person / Time
Site:	SHINE Medical Technologies
Issue date:	05/07/2024
From:	Bartelme J SHINE Technologies
To:	Office of Nuclear Reactor Regulation, Document Control Desk
Shared Package
ML24128A215	List: ML24128A216 ML24128A218
References
2024-SMT-0025
Download: ML24128A216 (1)

Text

THIS LETTER CONTAINS PROPRIETARY INFORMATION IN ACCORDANCE WITH 10 CFR 2.390 3400 Innovation Ct.

• Janesville, WI 53546

• 877.512.6554

• info@shinemed.com

• www.SHINEtechnologies.com May 7, 2024 2024-SMT-0025 10 CFR 50.71(b)

U.S. Nuclear Regulatory Commission ATTN: Document Control Desk Washington, DC 20555 SHINE Technologies, LLC Submittal of Annual Financial Report SHINE Technologies, LLC (SHINE) hereby submits its annual financial report, including certified financial statements, in accordance with the requirements of 10 CFR 50.71(b). provides the annual financial report of Illuminated Holdings, Inc. (Illuminated).

SHINE is a subsidiary of Illuminated. SHINE requests that the NRC withhold Enclosure 1, in its entirety, from public disclosure under 10 CFR 2.390. provides an affidavit supporting the proprietary treatment of the SHINE proprietary information contained in Enclosure 1, pursuant to 10 CFR 2.390. SHINE requests that the NRC withhold Enclosure 1, in its entirety, from public disclosure under 10 CFR 2.390. Upon removal of Enclosure 1, this letter is uncontrolled.

If you have any questions, please contact me at 608/210-1735.

I declare under the penalty of perjury that the foregoing is true and correct.

Executed on May 7, 2024.

Very truly yours, Jeff Bartelme Senior Director of Licensing and Regulatory Affairs SHINE Technologies, LLC Docket No. 50-608 cc:

Project Manager, USNRC SHINE General Counsel Supervisor, Radioactive Materials Program, Wisconsin Division of Public Health (w/o Enclosure 1)